Startup Ansa Bio lands $68M to go long with enzymes approach to DNA synthesis - MedCity News
4/11/2022 12:00:00 AM3 years 10 months ago
by Frank Vinluan
by Frank Vinluan
The DNA currently used in genetic medicines research is synthesized by chemical methods. Ansa Biotechnologies employs faster and less expensive enzymes-based technology, and the startup has raised capital to scale up operations as it prepares to launch its se…
Genetic medicines R&D is making strides with more complex DNA molecules. While these long sequences of synthetic DNA are key for developing gene and cell therapies as well as antibodies and other… [+5489 chars]
full article...